FINWIRES · TerminalLIVE
FINWIRES

Keysight Likely to Post Stronger Fiscal Q2 Growth on AI, Aerospace Demand, Morgan Stanley Says

By

Keysight Technologies (KEYS) could deliver stronger-than-expected fiscal Q2 growth as demand tied to artificial intelligence data centers and aerospace and defense markets continues to "strengthen," Morgan Stanley said in a report Friday.

The investment bank said recent results from Viavi Solutions (VIAV) and Anritsu reinforced positive trends in AI networking, data center testing and aerospace and defense demand ahead of Keysight's fiscal Q2 earnings report, according to the report.

Keysight is scheduled to release its Q2 financial results, after the close of the stock market on May 19.

Investors are "likely expecting" fiscal Q2 orders of about $1.71 billion to $1.72 billion and revenue near $1.75 billion, though orders could come in slightly lower at roughly $1.68 billion to $1.70 billion because of the timing of a large aerospace and defense deal, "that may make sequentials more challenging," the report said.

Keysight may need to exceed revenue expectations by about $50 million and raise full-year guidance closer to 25% growth to "sustain momentum," Morgan Stanley said.

Morgan Stanley has an equal weight rating on Keysight Technologies and raised its price target to $305 from $268.

Price: $351.76, Change: $-9.80, Percent Change: -2.71%

Related Articles

Wire

Aardvark Therapeutics' Investigational New Drug Application for ARD-101 Put on Clinical Hold by FDA

Aardvark Therapeutics (AARD) said late Thursday the US Food and Drug Administration placed a full clinical hold on its investigational new drug application for ARD-101 to treat hyperphagia associated with Prader-Willi Syndrome.The hold applies to all ongoing clinical studies under the IND, the company said, adding that it is in discussions with the FDA for resolution of the clinical hold and to fix a path forward for the drug candidate.The company also plans to unblind clinical data from the HERO and OLE trials to assess the totality of efficacy and safety data, according to the company.The company said it had $91.2 million in cash and cash equivalents as of March 31, adequate to fund operations into mid-2027.

$AARD
Wire

Sky Harbour Q1 Loss Narrows, Revenue Rises; Shares Fall After Hours

Sky Harbour Group (SKYH) reported a Q1 loss late Thursday of $0.16 per diluted share, narrowing from a loss of $0.19 a year earlier.Analysts polled by FactSet expected a loss of $0.13.Revenue in the three months ended March 31 rose to $8.73 million from $5.59 million a year earlier.Analysts surveyed by FactSet expected $9.8 million.Sky Harbour shares fell 4.9% in after-hours trading.

$SKYH
Wire

KinderCare Learning Q1 Adjusted Earnings Fall, Revenue Rises; Shares Drop After Hours

KinderCare Learning (KLC) reported Q1 adjusted earnings late Thursday of $0.04 per diluted share, down from $0.23 a year earlier.Analysts surveyed by FactSet expected a loss of $0.01.Revenue in the three months ended April 4 rose to $672.5 million from $668.2 million a year earlier.Analysts surveyed by FactSet expected $669.1 million.The company boosted full-year adjusted EPS guidance to $0.15 to $0.25 from the previous forecast of $0.10 to $0.20. It affirmed the revenue outlook of $2.7 billion to $2.75 billion.Analysts expect EPS of $0.15 on revenue of $2.71 billion.KinderCare shares fell 6.2% in after-hours trading.

$KLC